Mats Walder
11 – 20 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Molecular Epidemiology of Metallo-beta-Lactamase-Producing Pseudomonas aeruginosa Isolates from Norway and Sweden Shows Import of International Clones and Local Clonal Expansion
(
- Contribution to journal › Article
- 2009
-
Mark
Antimicrobial activity of tigecycline and comparative agents against clinical isolates of staphylococci and enterococci from ICUs and general hospital wards at three Swedish university hospitals
(
- Contribution to journal › Article
- 2007
-
Mark
Pharmacodynamic studies of vancomycin, metronidazole and fusidic acid against Clostridium difficile
(
- Contribution to journal › Article
- 2006
-
Mark
Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation
(
- Contribution to journal › Article
-
Mark
Penicillin-resistant pneumococci in Sweden 1997-2003: Increased multiresistance despite stable prevalence and decreased antibiotic use
(
- Contribution to journal › Article
-
Mark
The throat: An important site for MRSA colonization.
(
- Contribution to journal › Article
- 2003
-
Mark
Activity of three disinfectants and acidified nitrite against Clostridium difficile spores.
(
- Contribution to journal › Article
- 2000
-
Mark
Alpha1-antitrypsin deficiency (PiZ) may be a risk factor for duodenal ulcer in patients with Helicobacter pylori infection
(
- Contribution to journal › Article
- 1997
-
Mark
Antimicrobial susceptibility testing in Sweden. III. Methodology for susceptibility testing
(
- Contribution to journal › Article
- 1992
-
Mark
Pharmacokinetics of ceftazidime in acutely ill hospitalised elderly patients
(
- Contribution to journal › Article